New findings suggest women want aesthetic providers who understand how hormonal changes affect their skin and treatment outcomes.


Seventy-four percent of women say menopause increased their interest in aesthetic treatments, according to new survey findings released by Revance in partnership with NewBeauty’s BeautyEngine. The findings suggest that women value providers who understand how hormonal changes may affect aesthetic care.

The survey of 1,279 women ages 23 to 78 was announced by Revance, a global aesthetics, regenerative, and consumer skincare company, as part of a broader push to advance what the company describes as menopause-informed aesthetic care.

Patients Seeking Integrated Care

Beyond the headline finding on increased interest, the survey revealed that 68% of respondents said they find the idea of receiving aesthetic and hormone care within the same practice appealing, and 85% said it is important that their aesthetic healthcare provider understands the unique impacts of perimenopause and menopause.

Among women currently in perimenopause, menopause, or post-menopause, 63.6% said it is very important that their aesthetic healthcare provider understands perimenopause and menopause.

The findings also suggest that women may notice changes in treatment effectiveness during menopause. Among respondents who had previously received aesthetic treatments, more than one-third said they felt treatments were less effective than before entering perimenopause or menopause, while nearly half reported that results did not last as long.

“For many, aesthetics and menopause care have largely existed in separate conversations, despite the significant impact hormonal changes can have on skin health, treatment expectations, and overall confidence,” says Adelle Walker, chief marketing officer, aesthetics at Revance, in a release. “What we’re seeing now is the emergence of a patient who expects providers to understand the full spectrum of aging. This shift represents an important opportunity for the aesthetics industry to better serve women through education, personalization, and treatment strategies that reflect their changing needs.”

Interest in Regenerative Treatments

Among women in perimenopause, menopause, or post-menopause, 39% reported having shifted toward regenerative aesthetic options, while 55% expressed interest in peptide injections and 61% said they would be more likely to receive an aesthetic treatment featuring peptides.

Loss of firmness emerged as the leading skin-related concern among respondents. It was cited by 74%, followed by fine lines and wrinkles (66%), changes in the jawline and neck (47%), and facial volume loss (46%).

ID 483426640 © Prostockstudio | Dreamstime.com